Is Methylcobalamin registered with the SFDA?

The SFDA human drug list (edition 4-2026, as published by the Council of Health Insurance) lists 5 valid registrations of Methylcobalamin, including COBAL 500MCG TAB (500 µg, Film-coated tablet, SAR 20.75); METHYCOBAL 500 MCG TABLET (500 µg, Tablet, SAR 24.00); METHYCOBAL 500 mcg injection (500 µg, Injection, SAR 59.80); Nervamine (500 µg, Film-coated tablet, SAR 20.80); Restain (500 µg, Film-coated tablet, SAR 22.80).

Active substance

Methylcobalamin

SFDA 5

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade name	Strength	Form · route	Pack	Public price	Type	Company	Status
COBAL 500MCG TAB	500 µg	Film-coated tablet · Oral use	30 Blister	SAR 20.75	Generic · OTC	The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM)	Valid
METHYCOBAL 500 MCG TABLET	500 µg	Tablet · Oral use	30 Blister	SAR 24.00	Generic · OTC	EISAI	Valid
METHYCOBAL 500 mcg injection	500 µg	Injection · Intravenous use	10 Ampoule	SAR 59.80	Generic · Prescription	EISAI	Valid
Nervamine	500 µg	Film-coated tablet · Oral use	30 Bottle	SAR 20.80	Generic · OTC	Med City Pharma	Valid
Restain	500 µg	Film-coated tablet · Oral use	30 Blister	SAR 22.80	Generic · OTC	SPIMACO ADDWAEIH	Valid

Indications — CHI Daman Drug Formulary

VITAMIN B12 DEFICENCY ANEMIA

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.